WSJ’s blog on health and the business of health. At a Morgan Stanley conference today, Clark was asked about all the bad press the company has been getting: Is Merck not providing the positive stories or are the media not interested? “The answer to ...
Wyeth can’t seem to shake allegations of past manufacturing improprieties with its blockbuster vaccine Prevnar. The drug maker’s annual report, filed this morning, disclosed that two former Wyeth employees accused the drug maker of making false claims ...
stock rose Monday on renewed speculation that the pharmaceutical company might be acquired by a larger rival. Shares of Marlborough, Mass.-based Sepracor, which markets the insomnia drug Lunesta, closed up $4.63, or 9.3 percent, to $54.15 ...
Help us add to our database, by linking this writer their entry in Wikipedia or Source Watch, or by suggesting that we remove it from our index.